Hillsdale Investment Management’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-170
Closed -$7.75K – 658
2025
Q4
$7.75K Buy
+170
New +$7.57K ﹤0.01% 612
2025
Q1
– Sell
-220
Closed -$6.29K – 601
2024
Q4
$6.29K Sell
220
-50
-19% -$1.39K ﹤0.01% 554
2024
Q3
$7.19K Hold
270
– – ﹤0.01% 528
2024
Q2
$6.93K Buy
+270
New +$6.05K ﹤0.01% 510
2014
Q3
– Sell
-33,900
Closed -$303K – 542
2014
Q2
$303K Hold
33,900
– – 0.07% 211
2014
Q1
$338K Hold
33,900
– – 0.09% 150
2013
Q4
$376K Hold
33,900
– – 0.11% 136
2013
Q3
$237K Buy
+33,900
New +$230K 0.07% 266

Other funds holding AORT

Hillsdale Investment Management's AORT Position: Q1 2026 in Review

Hillsdale Investment Management sold out of Artivion (AORT) in Q1 2026, closing a stake of 170 shares — an estimated $7.75K sold.

Hillsdale Investment Management first reported a position in AORT in Q3 2013 and held it in 8 quarters. The position peaked at $376K in Q4 2013. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Hillsdale Investment Management reported no remaining Artivion position as of Q1 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 170 Artivion shares in Q1 2026, an estimated $7.75K.
  • Hillsdale Investment Management first reported a position in Artivion in Q3 2013 and held it in 8 quarters.
  • Hillsdale Investment Management's Artivion position peaked at $376K in Q4 2013.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.